PARINDA PARIKH: Open Payments
NPI 1851353213 · WHITE PLAINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,430 in 365 payments from 22 companies in 2025. Trend: 2023 $25,484 · 2024 $42,335 · 2025 $107,430
Speaker / faculty: $85,880Travel & lodging: $9,672Food & beverage: $7,555Consulting: $4,120Education: $202
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 71 | $43,591 |
| Teva Pharmaceuticals USA, Inc. | 37 | $27,855 |
| Otsuka America Pharmaceutical, Inc. | 28 | $16,282 |
| ABBVIE INC. | 52 | $12,786 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $3,244 |
| Alkermes, Inc. | 20 | $1,256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $733 |
| Vanda Pharmaceuticals Inc. | 19 | $297 |
| Neurocrine BioSciences, Inc. | 21 | $266 |
| Lundbeck LLC | 13 | $187 |
Products named: COBENFY, UZEDY, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, LYBALVI, CAPLYTA, ARISTADA.
Industry payments across NY — which companies pay providers there.
